16 June, 2015 by The TZ Newswire Staff Comments Off on Chinese Corporations Become Stock Speculators, Joining Housewives, Banana Vendors
Chinese Corporations Become Stock Speculators, Joining Housewives, Banana Vendors
It’s no secret that things are getting tougher for China’s manufacturing sector as the country embarks on a difficult transition from an investment-driven economy to a model led by services and consumption. Domestic demand for metals has fallen as “idle cranes, empty construction sites, and abandoned buildings” (to quote Bloomberg) betray a sharp economic deceleration.
16 June, 2015 by The TZ Newswire Staff Comments Off on JPM’s Walk Through What Greek Capital Controls Would Look Like
JPM’s Walk Through What Greek Capital Controls Would Look Like
Once upon a time, merely suggesting that a Eurozone country may be kicked out, let alone suffer capital controls, was enough to get one sued by the Hague for crimes against humanity, if not outright droned. Now, and as has been the case for the past 4 months, that it is the Troika’s explicit intent to foment a depositor panic and instigate a bank run in Greece with the hope of overthrowing the Tsipras government, everyone is allowed to chime in.
16 June, 2015 by The TZ Newswire Staff Comments Off on Cramer: This stock could go up HUGE!
Cramer: This stock could go up HUGE!
“Mad Money” host Jim Cramer plays Mad Math with the upside potential of combining two major digital players.
16 June, 2015 by The TZ Newswire Staff Comments Off on We Might As Well Face It – America Is Addicted To Debt
We Might As Well Face It – America Is Addicted To Debt
16 June, 2015 by The TZ Newswire Staff Comments Off on The world’s most expensive city for expats
The world’s most expensive city for expats
In the world’s most expensive city for expats, a fast food meal will set you back $17 and a non-descript apartment costs a whopping $6,800 a month.
16 June, 2015 by The TZ Newswire Staff Comments Off on High Tech Biotech Alkermes (ALKS) Tries To Recover From A Tough Setback
High Tech Biotech Alkermes (ALKS) Tries To Recover From A Tough Setback
Alkermes (ALKS) appears to be a highly specialized Biotech working on rare conditions to help with managing the effect of the condition. Recently Alkermes (ALKS) took a tumble and the stock dropped from $75 to $55. Can it recover?
First of all, the SCTR has popped back up. The relative strength line shown in white is still climbing. The price clearly broke out of the downtrend and looks to have more upside. The MACD on this stock rarely goes below zero.
16 June, 2015 by The TZ Newswire Staff Comments Off on What is a Non-Objecting Beneficial Owner?
What is a Non-Objecting Beneficial Owner?
As an investor, you may be a non-objecting beneficial owner and not even know it.